News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Sales & Marketing

Latest News

April 1st 2005
Phase Six: Regain Confidence
By Patrick Clinton

In a bright airy office above fifth avenue in New York, Lynn O'Connor Vos is talking about topics dear to her heart: trust-and how pharma can regain it-the need to put physicians back in the center of pharmaceutical marketing, and reinvention, a theme in her own life and the core to her approach to business.

i1-161829-1408696713277.jpg
April 1st 2005

The Problem With Bob

By Patrick Clinton
April 1st 2005

Good News Bad News

By Stephen J. Porth, PhD, George P. Sillup, PhD
i1-153027-1408695914492.jpg
March 1st 2005

More Than Just a Pretty Color

By David R. Schoneker
i1-153003-1408695933028.jpg
March 1st 2005

Washington Report: The Main Event Begins

By Jill Wechsler, Pharm Exec’s Washington Correspondent
Advertisement

Advertisement
i1-146581-1408696441583.jpg

Medicare: D Day

ByKevin Barnett
February 1st 2005

For companies that are prepared, Part D represents a great opportunity. For others, failing to react quickly enough could be a costly mistake.

i4-146582-1408696438902.gif

The Sampling Subsidy

ByNancy Lurker,Bob Caprara
February 1st 2005

Physicians give only 25 percent of samples to newly diagnosed patients, along with a prescription.

The Rise and Fall of Pharma Reputations

ByDoretta W. Gasorek,Jeffrey T. Resnick
February 1st 2005

As a reputation driver, ethical behavior has increased steadily in importance over the last three years.

  • Prev
  • 1
  • More pages
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • Prev
Advertisement
Advertisement

Trending on PharmExec

1

Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients

2

Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths

3

Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint

4

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

5

How Will the Inclusion of GLP-1s in Medicaid and Medicare Impact Businesses?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us